Invitation to presentation of Bactiguard’s interim report on November 12

Bactiguard Holding AB publishes the interim report for the third quarter on Thursday 12 November at 8:00 CET.

In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on November 12. CEO Christian Kinch and CFO Fredrik Järrsten will present the interim report and answer questions.

The report and a presentation for the conference call will be available at Bactiguard’s website www.bactiguard.com from 8:00 CET on the same day.   

To participate in the conference call, please dial +46 8 566 427 00

For further information, please contact:
Ulrika Berglund, Head of External Affairs, mobile: +46 708 80 04 07

For questions about participation in the conference call, please contact:
Susann Remnert, Communication Manager, mobile: +46 709 195 342, e-mail: susann.remnert@bactiguard.se

About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, Latin America and Southern Africa. The company has market presence in some 50 countries and has about 70 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com